Richard Blumenthal

Overview

Senator Richard Blumenthal of Connecticut has compiled a substantial voting record of 703 votes in the U.S. Senate. His record reflects consistent alignment with progressive policy priorities across healthcare, environmental protection, and social spending, while frequently opposing measures backed by the Republican majority. On healthcare, Blumenthal has supported efforts to lower out-of-pocket costs and maintain federal oversight of Medicare programs, while opposing nominees he viewed as insufficiently committed to public health mandates. On defense and foreign policy, he has backed congressional authority over military engagements — notably voting to require congressional authorization for military action involving Iran — while opposing certain defense authorization bills and executive branch nominees. Blumenthal's voting pattern on environment and energy issues shows strong support for maintaining environmental regulations, including rules governing chemical reporting requirements like PFAS standards. On fiscal matters including budgets and taxation, his votes reflect support for progressive tax policies and opposition to spending packages that he viewed as insufficiently protective of social programs. Across nearly all categories, Blumenthal's high rate of 'Nay' votes reflects his position as a member of the minority party during a period when the Senate majority advanced legislation and nominations he frequently opposed. This is a common pattern for senators in the minority and should be understood in that context rather than as an indication of obstructionism.

Key Positions

• •Voted to require congressional authorization before military action against Iran, supporting legislation to remove U.S. Armed Forces from unauthorized hostilities (July 2026).
• •Supported maintaining PFAS chemical reporting and recordkeeping requirements by voting to disapprove the EPA's rule weakening those standards (August 2026).
• •Voted in favor of a measure to create a point of order against budget reconciliation bills that do not lower out-of-pocket healthcare costs (April 2026).
• •Supported congressional disapproval of changes to the Medicare prior authorization WISeR Model, voting to preserve existing patient protections (July 2026).
• •Consistently opposed executive branch nominees across multiple departments, reflecting disagreement with the current administration's policy direction.
• •Voted in favor of trade-related measures in a majority of opportunities (4 of 6 votes), suggesting relative openness to international trade agreements.
• •Supported housing-related legislation at a notably higher rate than most other categories, splitting evenly with 6 'Yea' and 6 'Nay' votes out of 12.